GONUTS has been updated to MW1.31 Most things seem to be working but be sure to report problems.
PMID:22230317
Citation |
Hsu, WL, Chung, PJ, Tsai, MH, Chang, CL and Liang, CL (2012) A role for Epstein-Barr viral BALF1 in facilitating tumor formation and metastasis potential. Virus Res. 163:617-27 |
---|---|
Abstract |
Epstein-Barr virus (EBV) is a ubiquitous human herpesvirus that triggers transformation and tumorigenesis of latently infected B cells in vitro. BALF1, a Bcl-2-like EBV gene expressed in both latent and lytic stages, was recently characterized in EBV-infected cells; however, the role and function of BALF1 has remained elusive. Here, we demonstrate that BALF1 expression alters cellular morphology. Importantly, BALF1 promotes cellular transformation, with tumorigenicity assays showing larger and substantially greater numbers of tumors in BALF1 transfectant-injected mice compared to mice injected with pcDNA control transfectants. In addition, BALF1 expression increases cell survival under low-serum conditions, an effect that is attributable to suppression of apoptosis, not to promotion of cell-cycle progression. Furthermore, BALF1 transfectants exhibit markedly increased tumor metastasis in vitro and in vivo. Taken together, these findings suggest that BALF1 may be a new tumor marker for EBV diagnosis and provide a new direction for research on treatments of EBV-associated tumors. |
Links |
PubMed Online version:10.1016/j.virusres.2011.12.017 |
Keywords |
Animals; Disease Models, Animal; Herpesvirus 4, Human/pathogenicity; Lymphoma/pathology; Lymphoma/virology; Male; Mice; Mice, Inbred BALB C; Neoplasm Metastasis/pathology; Viral Proteins/metabolism; Virulence Factors/metabolism |
edit table |
Significance
Annotations
Gene product | Qualifier | GO Term | Evidence Code | with/from | Aspect | Extension | Notes | Status |
---|---|---|---|---|---|---|---|---|
GO:0043066: negative regulation of apoptotic process |
ECO:0000314: |
P |
Figure 4 presents the role of BALF1 in regulating apoptosis. After being placed in an environment to cause serum starvation-induced apoptosis, the control pcDNA transfectants showed a statistically significant higher number of apoptotic control cells in comparison to BALF1 transfectants (4A). Part 4B shows 38.9% of apoptotic pcDNA-transfectants, which was about 4-10 fold increase from BALF1-transfectants. Figure 4C represents that the BALF1 expressing cells showed a much higher survival rate in serum starvation conditions which seems to be attributable to suppression of apoptosis. |
complete | ||||
involved_in |
GO:0043066: negative regulation of apoptotic process |
ECO:0000314: direct assay evidence used in manual assertion |
P |
Seeded From UniProt |
complete | |||
See also
References
See Help:References for how to manage references in GONUTS.